Kristen B. Rosati
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
2017 Annual Report
2017 Annual Report Phoenix 2800 North Central Avenue, Suite 1530, Phoenix, Arizona 85004 602.343.8324 Tucson c/o Global Advantage 9070 South Rita Road, Suite 1550, Tucson, Arizona 85747 520.382.3281 aztechcouncil.org [email protected] Table of Contents 02 About the Arizona Technology Council 04 Letter from the President + CEO 06 Introduction + Overview 08 Public Policy Advocacy 10 Signature Events 16 Marketing + Communications 18 Technology Employment 21 TechTerra Program 22 Business Essentials Program 26 Standing Committees 30 Functional Committees 32 Peer Groups 34 STEM Education Programs 38 In the Community 39 By the Numbers 40 Board of Directors 42 Staff Members 44 2017 Council Members 50 Sponsors ARIZONA TECHNOLOGY COUNCIL TECHNOLOGY ARIZONA 2 ANNUAL REPORT 2017 ANNUAL 1 About the Arizona Technology Council The Arizona Technology Council is Arizona’s premier trade association for science-and technology-driven companies. Recognized as having a diverse professional business community, the Council works towards furthering the advancement of technology in Arizona through leadership, education, advocacy, and social action. The Council offers numerous events, educational forums, and business conferences that bring together leaders, professionals, and visionaries to make an impact on the technology industry. These interactions contribute to the Council’s culture of growing member businesses and transforming technology in Arizona. To become a member or to learn more about the Council, please visit www.aztechcouncil.org. Our Mission The Arizona Technology Council is the driving force behind making our state the fastest-growing technology hub in the nation, connecting and empowering Arizona’s technology community. ARIZONA TECHNOLOGY COUNCIL TECHNOLOGY ARIZONA 2 3 Letter from the President + CEO It’s not often that the technology story as job interviews and the first day of Digging deeper into the numbers, of the year comes when the calendar work. -
June 6, 2003 a New Perspective on Business
J UMP BUTTONS. CLICK ON PHOTO TO GO TO: UNSHACKLED PUBLISHING PG 9 BECKETT AND BECKETT PHOTOGRAPHY PG 10 CONGRESSIONAL MINORITY BUSINESS SUMMIT PG 13 HOME PG 4 THE EBONY CACTUS magazine Vol. 2. No. 10 June 6, 2003 A New Perspective on Business Congressional Minority Business Summit Inside: Unshackled Publishing Beckett and Beckett Photography www.TheEbonyCactus.com Making it Happen! Coordinating & Management Services, LLC. A Full Service Event Planning & Management Company” SERVICES Conference Conventions Festivals Concerts Banquets Meetings Company Picnics Company Parties Corporate Events Event Marketing Soliciting Sponsorship Workshops “Let us help you plan your next event” Contact: Ron Edwards @ (623) 521-4879 P.O. Box 904 1700 Thomas Rd Phoenix, AZ 85001-0904 Phoenix, AZ 85016 An Affiliate of the DiamondRock Entertainment Corp. Life Strategies Consulting Angela Miller-Brooks Unique HR Solutions, Professional Writing and Public Relations services P.O. Box 24982 Tempe, Arizona 85285-4982 Home 602-821-8191/ [email protected] We’re Behind The Scene Keeping You On The Scene Mention you saw this in The Ebony Cactus 2 THE EBONY CACTUS magazine Vol. 2 No. 10 June 6, 2003 The Ebony Cactus magazine Home studios in the country for over 30 years. John has a flair for making art wizardry. He’s produced some of the most memorable magazine imprints in American culture during the 20th century. Beckett is responsible for bringing countless Fortune 500 businesses into the homes of millions through a simple camera lens. Pg 10 Unshackled Publishing: Former Texan and nationally acclaimed author Alexus Rhone pulls no punches when introducing teens to the low-down of growing up through her series of novels. -
Clinical and Translational Science (CTS) Scholars Program (KL2)
Clinical and Translational Science Scholars Program 2020-2021 1 Institute for Clinical Research Education Clinical and Translational Science Scholars Program Table of Contents Welcome to the Clinical and Translational Science Scholars Program ……………..p# Contact Information Faculty & Staff 4 Multidisciplinary Advisory Committee (MAC) 6 Program Expectations and Overview Expectations for the Scholars 7 Program Requirements 8 Mock Review Sessions 11 Regulatory Requirements Publication Acknowledgment, Other Support and the NIH Biosketch 12 NIH Inclusion Monitoring 14 NIH Prior Approval and Notification – Policies & Procedures 15 Guidelines for KL2 Career Development Funds 17 CITI Modules 22 Association for Clinical and Translational Science (ACTS) Save the Date 24 Program Evaluation Evaluation/Tracking 25 Appendix A: Authorship Agreement form Appendix B: Clinical and Translational Science Fellowship Mentoring Expectations and Contract Appendix C: CTS Scholars Program Purchasing Form 2 Clinical and Translational Science Scholars Program Welcome Welcome to the Institute for Clinical Research Education (ICRE) at the University of Pittsburgh, and to your Clinical and Translational Science (CTS) Scholars Program (KL2). This program, offered by the ICRE and the Clinical and Translational Science Institute (CTSI), provides individualized, competency-based training in rigorous research methodologies for the design and conduct of high-quality translational research. The CTS Scholars Program provides courses, seminars, workshops, and experiential training to build essential translational research skills in team science, leadership, stakeholder engagement, communication, and moving innovations to commercialization. This handbook points you to important information that will help you throughout your time at the ICRE. However, it is likely you will have questions that are not answered here. Do not hesitate to contact any of us to let us know how we can be of help. -
Bradley Shwer
Bradley Shwer PARTNER 3200 North Central Avenue, Suite 1560 [email protected] Phoenix AZ 85012 Direct: 602-682-6106 Main: 602-682-6100 Fax: 602-682-6149 Fax: 602-682-6149 Brad is a co-founding partner of Thorpe Shwer who practices in the areas of business and commercial litigation, personal injury torts, and products liability. Along with his partner Bill, Brad co-founded Thorpe Shwer to create a law firm that provides quality litigation services, as well as a dedication to strong client relationships, efficient and aggressive representation, and personal service. In other words, Brad believes that clients should receive top-shelf quality plus top-shelf service. He represents his clients in a variety of contractual disputes, business tort claims, personal injury defense, product liability claims, collections, franchise litigation, premises liability claims, insurance litigation, and deficiency actions. Brad has litigated and tried cases in numerous states around the country in both federal and state court. His clients are a diverse group ranging from Fortune 500 companies to individual entrepreneurs. They include national franchisors, massage and spa providers, big-box retailers, ridesharing companies, restaurants, bars, product manufacturers, transportation companies, railroads, financial institutions, software companies, real estate entities, medical practices, moving companies, and a wide variety of small businesses. Prior to co-founding Thorpe Shwer, Brad served as a Director at Fennemore Craig. Brad is well-recognized and respected in the Arizona legal community. including being named of the top 50 lawyers in Arizona by Southwest Super Lawyers and one of the top 100 lawyers in Arizona by AZ Business Magazine. -
Challenges of T3 and T4 Translational Research | Vukotich, Jr. | Journal Of
Home About Announcements Current Issue Past Issues Contributors Forum Home > Volume 12, Issue 2, 2016 > Vukotich, Jr. Journal Help Journal of Research Practice Volume 12, Issue 2, Article P2, 2016 CURRENT ISSUE Provocative Idea: Subscribe Challenges of T3 and T4 Translational Research USER Charles J. Vukotich, Jr. School of Medicine, University of Pittsburgh Username Pittsburgh, PA, UNITED STATES Password [email protected] Remember me Abstract JOURNAL CONTENT Search Translational research is a new and important way of thinking about research. It is a major priority of the National Institutes of Health (NIH) in Search Scope the United States. NIH has created the Clinical and Translational Science All Awards to promote this priority. NIH has defined T1 and T2 phases of translational research in the medical field, in order to bring the benefits of Browse scientific results into communities. Current discussions focus on clarifying By Issue the subsequent phases of translational research necessary to achieve the By Author intended social impact of research. This article suggests that T3 translational By Title research could aim at getting research out of the highly controlled environment of the academic health center and into the real world. Likewise, ARTICLE TOOLS it suggests T4 translational research could aim at policy development Abstract through policy analysis and evaluation, cost-benefit analysis, and Print this article surveillance studies. Translational research has challenges beyond definitions. Translational research is incomplete at any level unless Indexing metadata appropriate steps are taken to communicate the results to relevant Email this article (Login stakeholders. It appears that communication is currently suboptimal at all required) levels of translation. -
Career Education and Enhancement for Health Care Research Diversity (CEED) Program Handbook
Career Education and Enhancement for Health Care Research Diversity (CEED) Program Handbook University of Pittsburgh School of Medicine Institute for Clinical Research Education July 2019 Contents I. Objective ............................................................................................................................................................................ 2 II. Course Components ...................................................................................................................................................... 2 III. Eligibility: ..................................................................................................................................................................... 2 IV. Funding: ........................................................................................................................................................................ 4 V. Academic Policy and Procedures ............................................................................................................................ 5 A. Statute of Limitations .............................................................................................................................................. 5 B. Cross Registration ..................................................................................................................................................... 5 C. Waiver of Requirements ....................................................................................................................................... -
Instructions and Template for Creating a Position Description
POSITION DESCRIPTION Position Title: Research Operations Manager Organisation Unit: Faculty of Medicine, UQ Diamantina Institute Position Number: 3042523 Type of Employment: Fixed Term, Full Time Classification: HEW 7 THE UNIVERSITY OF QUEENSLAND The University of Queensland (UQ) contributes positively to society by engaging in the creation, preservation, transfer and application of knowledge. UQ helps shape the future by bringing together and developing leaders in their fields to inspire the next generation and to advance ideas that benefit the world. UQ strives for the personal and professional success of its students, staff and alumni. For more than a century, we have educated and worked with outstanding people to deliver knowledge leadership for a better world. UQ ranks in the world’s top universities, as measured by several key independent ranking, including the Performance Ranking of Scientific Papers for World Universities (43), the US News Best Global Universities Rankings (52), QS World University Rankings (47), Academic Ranking of World Universities (55), and the Times Higher Education World University Rankings (60). UQ again topped the nation in the prestigious Nature Index and our Life Sciences subject field ranking in the Academic Ranking of World Universities was the highest in Australia at 20. UQ has an outstanding reputation for the quality of its teachers, its educational programs and employment outcomes for its students. Our students remain at the heart of what we do. The UQ experience – the UQ Advantage – is distinguished by a research enriched curriculum, international collaborations, industry engagement and opportunities that nurture and develop future leaders. UQ has a strong focus on teaching excellence, winning more national teaching excellence awards than any other in the country and attracting the majority of Queensland's highest academic achievers, as well as top interstate and overseas students. -
Health Care Industry Overview
PHOENIX FORWARD HEALTH CARE INDUSTRY OVERVIEW Produced by the University of Phoenix TABLE OF CONTENTS Executive Summary ………………………….………………...…………. 5 Chapter 1: Introduction ………………………….………………...……... 7 Chapter 2: Health Care Sector Defined………………………………..…9 Chapter 3: History, Background & National Trends..………………... 12 Chapter 4: Greater Phoenix Health Care Industry ……………...……. 18 Chapter 5: Moving Forward to the Greater Phoenix Health Care Industry of Tomorrow …………...………………………..………….. 30 Chapter 6: Conclusion …………………………………………………... 34 References …………………………………………………………….….. 36 Contact Information……..…………………………………….………… 37 Greater Phoenix Chamber of Commerce………...………………..…... 38 Phoenix Forward Health Care Industry Overview 4 Executive Summary Health care has been a driving factor for Greater sector. In doing so, the report draws upon the Phoenix job growth in recent years, and the collective knowledge of key leaders in health region has the potential to become a national care who are vital job creators. health care hub. This report examines factors needed to spur economic growth so the health Businesses have several resource needs, care industry can reach that next level. As the including connecting with key public sector report outlines, there needs to be a focus on officials, development incentives, locating growing and retaining existing companies, in additional facility space, technical assistance, addition to attracting relocations. Over 80% of and workforce development. As the report job growth comes from companies already in notes, the biggest challenge of health care the region,1 making business retention the often leaders today is maintaining a full pipeline of overlooked but critically important economic qualified human capital ready to apply for and development strategy. The growth in local serve in available, well-paying jobs. Companies companies and workforce makes the region need help recruiting, developing, and retaining even more attractive to outside companies the best employees, so it is important to develop looking to expand here. -
California Water Service Group Announces Election of Shelly M
California Water Service Group Announces Election of Shelly M. Esque to Board of Directors June 27, 2018 SAN JOSE, Calif., June 27, 2018 (GLOBE NEWSWIRE) -- California Water Service Group (NYSE:CWT) today announced the election of Shelly M. Esque to the Company’s Board of Directors, effective June 27, 2018. Prior to her retirement in 2016, Esque, 58, served as Vice President and Global Director of Corporate Affairs at Intel Corporation, overseeing professionals in more than 35 countries responsible for enhancing Intel’s reputation as the world’s leading technology brand and corporate citizen. She also served as both president and chair of the Intel Foundation. “Given our commitment to excellence in corporate citizenship, Shelly is an excellent fit on our Board. She is a dynamic leader in her profession, and I know she will be a valuable asset to our team,” said Chairman Peter C. Nelson. In her capacity as a leader of Intel’s corporate social responsibility, community, education, foundation, and government relations worldwide, Esque represented Intel at numerous events, including the World Economic Forum, World Bank, UNESCO, and forums promoting women in the workplace. She received the Greater Phoenix Chamber of Commerce 2011 ATHENA Businesswoman of the Year Award for excellence in business and leadership, exemplary community service, and support and mentorship of other women. She was also recognized by AZ Business Magazine as one of the 50 Most Influential Women in Arizona. She is active on many non-profit boards, including Basis Charter Schools, Take the Lead, and the Boyce Thompson Arboretum, among others. “Enhancing relationships with our customers and communities is key to our Company’s continued success, and I look forward to having someone with Shelly’s expertise on our Board,” said President and Chief Executive Officer Martin A. -
ID :202-408- 5117 SEP 23'94 13 :57 No .021 P.16
BOB DOLE This documentID :202-408 is from the collections- 5117 at the Dole Archives, SEPUniversity 23'94 of Kansas 13 :57 No . 021 P . 16 http://dolearchives.ku.edu MEMORANDUM SEPTEMBER 23, 1994 TO: SENATOR DOLE FROM: JO-ANNE SUBJ: TODAY'S TRAVEL TO ARIZONA I spoke with both Jim Kolbe's and Bob Stump's offices to invite the Congressmen to fly out with you this afternoon. Kolbe has an earlier commitment in the District, so will be leaving before you do. Likewise, Stump has other plans. The other House Members from Arizona are Democrats. I also received a call from McCain's in-state Chief of Staff to indicate Gramm and McCain wou1d Jike to join in the press conference with you at 5:45 this afternoon·· if you object, she will make sure they're not included. I told her there would be no problem with this. Please let me know if you feel differently. By the way, you are being met by John Teets and then going to Dial's corporate headquarters for a tort refonn meeting. FYI, Dial pledged $50,000 to the RNC drive -- may be a good prospect for BAF. Page 1 of 101 This document is from the collections at the Dole Archives, University of Kansas http://dolearchives.ku.edu - Page 2 of 101 BOB DOLE This documentID: 20 is from2-4 the08 collections-5117 at the Dole Archives, SEPUniversity 23 of' 94Kansas 14: 25 No. 022 P.02 http://dolearchives.ku.edu FINAL Contact: Mo Taggart 703/684-7848 Beep 800/946-4646 pin# 1115689 SENATOR DOLE SCHEDULE -- SEPTEMBER 23-25, l 994 p- ARIZONA. -
Shelly M. Esque Shelly Esque Is a Vice President at Intel Corporation
Shelly M. Esque INTEL CORPORATION Shelly Esque is a Vice President at Intel Corporation, Global Director of the company’s Corporate Affairs Group, and President of the Intel Foundation. In this role, she oversees professionals in more than 35 countries working to enhance Intel’s reputation as the world’s leading technology brand and Corporate Citizen. A 15-year Intel veteran, Shelly joined Intel as Arizona Public Affairs Manager, then managed U.S. Public Affairs and Global Public Affairs. Ultimately, she drove the creation of the Corporate Affairs Group, adding Intel’s $100 million per year education efforts to her existing portfolio managing Intel’s Corporate Social Responsibility, environmental sustainability, community, foundation, and government relations efforts worldwide. Shelly has represented Intel at highly visible events including the Clinton Global Initiative, the World Economic Forum, World Bank and UNESCO education forums, the Women’s Network for a Sustainable Future as well as international Corporate Responsibility conferences. She regularly interviews with media and meets with key government leaders around the world. Shelly’s group has won many notable awards, including the Committee Encouraging Corporate Philanthropy’s Chairman’s Award for Intel® Teach, a program which has now trained 10 million teachers around the world. Shelly has a passion for coaching and mentoring women, attributing her success to guidance from women as she traversed her path from farm girl to college student (Arizona State University) to young professional and beyond. She is an active participant in Intel’s Network of Executive Women she regularly mentors Intel female employees and is a sought-after speaker for Women at Intel Network (WIN) conferences as she travels the world. -
A New Framework for Assessing the Health and Societal Benefits of Clinical and Translational Sciences
Citation: Clin Transl Sci (2018) 11, 77–84; doi:10.1111/cts.12495 C 2017 ASCPT. All rights reserved ARTICLE The Translational Science Benefits Model: A New Framework for Assessing the Health and Societal Benefits of Clinical and Translational Sciences Douglas A. Luke1,∗, Cathy C. Sarli2, Amy M. Suiter2, Bobbi J. Carothers1, Todd B. Combs1, Jae L. Allen3, Courtney E. Beers3 and Bradley A. Evanoff4 We report the development of the Translational Science Benefits Model (TSBM), a framework designed to support institutional assessment of clinical and translational research outcomes to measure clinical and community health impacts beyond biblio- metric measures. The TSBM includes 30 specific and potentially measurable indicators that reflect benefits that accrue from clinical and translational science research such as products, system characteristics, or activities. Development of the TSBM was based on literature review, a modified Delphi method, and in-house expert panel feedback. Three case studies illustrate the feasibility and face validity of the TSBM for identification of clinical and community health impacts that result from trans- lational science activities. Future plans for the TSBM include further pilot testing and a resource library that will be freely available for evaluators, translational scientists, and academic institutions who wish to implement the TSBM framework in their own evaluation efforts. Clin Transl Sci (2018) 11, 77–84; doi:10.1111/cts.12495; published online on 8 September 2017. Study Highlights WHAT IS THE CURRENT KNOWLEDGE ON THE TOPIC? WHAT THIS STUDY ADDS TO OUR KNOWLEDGE ✔ Most current knowledge on the topic of the value of clin- ✔ This study presents a framework that can be used to ical and translational research focuses on productivity mea- assess or evaluate these processes and outcomes.